Mechanisms of isorhamnetin inhibition of osteoclast differentiation: insights from molecular dynamics simulations and in vitro/in vivo experiments
BackgroundOsteoporosis (OP) represents a widespread bone remodeling disorder within the domain of orthopedics, markedly compromising the quality of life in the elderly population. The need to develop more efficient therapeutic approaches to attenuate bone resorption by suppressing the excessive acti...
Saved in:
| Main Authors: | Yi Zhou, Shaoshuo Li, Bowen Hong, Zihan Wang, Yang Shao, Mao Wu, Jianwei Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1551257/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trim21 deficiency alleviates osteoporosis by inhibiting osteoclast differentiation through regulating Txnip
by: Ya-Chen Peng, et al.
Published: (2025-08-01) -
Isorhamnetin alleviates symptoms and inhibits oxidative stress levels in rats with pulmonary arterial hypertension
by: Feng Chen, et al.
Published: (2024-12-01) -
Isorhamnetin Attenuates Isoproterenol-Induced Myocardial Injury by Reducing ENO1 (Alpha-Enolase) in Cardiomyocytes
by: Zhenli Guo, et al.
Published: (2025-05-01) -
Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts
by: Zhao W, et al.
Published: (2025-03-01) -
The Role of microRNA in the Regulation of Differentiation and the Functionality of Osteoblasts, Osteoclasts, and Their Precursors in Osteoporosis
by: Bulat I. Yalaev, et al.
Published: (2025-02-01)